相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeted Deletion of Centrin in Leishmania braziliensis Using CRISPR-Cas9-Based Editing
Rohit Sharma et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Leishmania Major Centrin Gene-Deleted Parasites Generate Skin Resident Memory T-Cell Immune Response Analogous to Leishmanization
Nevien Ismail et al.
FRONTIERS IN IMMUNOLOGY (2022)
Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis
Greta Volpedo et al.
NPJ VACCINES (2022)
Protective CD4+ Th1 cell-mediated immunity is reliant upon execution of effector function prior to the establishment of the pathogen niche
Leah S. Hohman et al.
PLOS PATHOGENS (2021)
Investigation of the antigenicity and protective efficacy of Leishmania promastigote membrane antigens in search of potential diagnostic and vaccine candidates against visceral leishmaniasis
Sarfaraz Ahmad Ejazi et al.
PARASITES & VECTORS (2020)
A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
Wen-Wei Zhang et al.
NATURE COMMUNICATIONS (2020)
Essential Role of Neutrophils in the Protective Immune Response Induced by a Live Attenuated Leishmania Vaccine
Parna Bhattacharya et al.
JOURNAL OF IMMUNOLOGY (2020)
Role of Host and Parasite MIF Cytokines during Leishmania Infection
Thomas Holowka et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2020)
Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy
Alti Dayakar et al.
FRONTIERS IN IMMUNOLOGY (2019)
miR-21 Expression Determines the Early Vaccine Immunity Induced by LdCen-/- Immunization
Sreenivas Gannavaram et al.
FRONTIERS IN IMMUNOLOGY (2019)
Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis
Elodie Petitdidier et al.
NPJ VACCINES (2019)
Leishmania Vaccines Entered in Clinical Trials: A Review of Literature
Mohammad Moafi et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2019)
Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model
Antara Banerjee et al.
JOURNAL OF IMMUNOLOGY (2018)
Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection
Alvaro Baeza Garcia et al.
NATURE COMMUNICATIONS (2018)
Centrin-Deleted Leishmania donovani Parasites Help CD4+ T Cells to Acquire Th1 Phenotype and Multi-Functionality Through Downregulation of CD200-CD200R Immune Inhibitory Axis
Rakesh K. Singh et al.
FRONTIERS IN IMMUNOLOGY (2018)
Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence
Shyam Sundar et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)
Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
Malcolm S. Duthie et al.
FRONTIERS IN IMMUNOLOGY (2018)
Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence
Thomas Holowka et al.
FASEB JOURNAL (2016)
Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis
Parna Bhattacharya et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters
Jacqueline Araujo Fiuza et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Modulation of innate immune Mechanisms to enhance Leishmania vaccine-induced immunity: Role of Coinhibitory Molecules
Sreenivas Gannavaram et al.
FRONTIERS IN IMMUNOLOGY (2016)
Cutaneous leishmaniasis: immune responses in protection and pathogenesis
Phillip Scott et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice
Parna Bhattacharya et al.
INFECTION AND IMMUNITY (2015)
Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection
Nelson D. Glennie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis
Ankita Thakur et al.
PARASITOLOGY INTERNATIONAL (2015)
Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4(+) T cells
Zhirong Mou et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum
Jacqueline Araujo Fiuza et al.
VACCINE (2015)
Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis
Sneha Anand et al.
SCIENTIFIC REPORTS (2015)
Characterization of Cross-Protection by Genetically Modified Live-Attenuated Leishmania donovani Parasites against Leishmania mexicana
Ranadhir Dey et al.
JOURNAL OF IMMUNOLOGY (2014)
Comparative analysis of resistant and susceptible macrophage gene expression response to Leishmania major parasite
Imen Rabhi et al.
BMC GENOMICS (2013)
Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs
Jacqueline Araujo Fiuza et al.
VACCINE (2013)
Stable T-bet+GATA-3+ Th1/Th2 Hybrid Cells Arise In Vivo, Can Develop Directly from Naive Precursors, and Limit Immunopathologic Inflammation
Michael Peine et al.
PLOS BIOLOGY (2013)
Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives
Ana Paula Fernandes et al.
CURRENT OPINION IN MICROBIOLOGY (2012)
Evaluation of Recombinant Leishmania Polyprotein Plus Glucopyranosyl Lipid A Stable Emulsion Vaccines against Sand Fly-Transmitted Leishmania major in C57BL/6 Mice
Nathan C. Peters et al.
JOURNAL OF IMMUNOLOGY (2012)
Phenotyping of circulating CD8+ T cell subsets in human cutaneous leishmaniasis
Ali Khamesipour et al.
MICROBES AND INFECTION (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria
Tiffany Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
Angamuthu Selvapandiyan et al.
JOURNAL OF TROPICAL MEDICINE (2012)
CD4+ T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis
T. S. L. Keesen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Persistence of Leishmania donovani Antibodies in Past Visceral Leishmaniasis Cases in India
Kamlesh Gidwani et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
The magnitude of CD4+T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice
L. Xin et al.
PARASITE IMMUNOLOGY (2011)
Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation
Eszter Deak et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform
Patricia A. Darrah et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Determination of CD4+and CD8+T cells in the peripheral blood of dogs with leishmaniosis before and after prolonged allopurinol monotherapy
E. Papadogiannakis et al.
VETERINARY JOURNAL (2010)
CD8+ T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis
Mahmoud Nateghi Rostami et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Intracellular Replication-Deficient Leishmania donovani Induces Long Lasting Protective Immunity against Visceral Leishmaniasis
Angamuthu Selvapandiyan et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-17 Promotes Progression of Cutaneous Leishmaniasis in Susceptible Mice
Susanna Lopez Kostka et al.
JOURNAL OF IMMUNOLOGY (2009)
Recruitment of CD8+ T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis
D. R. Faria et al.
PARASITE IMMUNOLOGY (2009)
Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis
Ifeoma Okwor et al.
VACCINE (2009)
Identification of Highly Specific and Cross-Reactive Antigens of Leishmania Species by Antibodies from Leishmania (Leishmania) chagasi Naturally Infected Dogs
A. M. Vale et al.
ZOONOSES AND PUBLIC HEALTH (2009)
Live attenuated Leishmania vaccines: a potential strategic alternative
Ricardo Silvestre et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L-major LV39 in BALB/c Mice
Catherine Ronet et al.
JOURNAL OF IMMUNOLOGY (2008)
A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses
Daniela Kamir et al.
JOURNAL OF IMMUNOLOGY (2008)
Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response
I. Ramos et al.
VACCINE (2008)
A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs
Rodolfo Cordeiro Giunchetti et al.
VACCINE (2008)
Vaccines for leishmaniasis in the fore coming 25 years
Clarisal B. Palatnik-de-Sousa
VACCINE (2008)
Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression
David J. Gregory et al.
INFECTION AND IMMUNITY (2008)
Measuring the Burden of Neglected Tropical Diseases: The Global Burden of Disease Framework
Colin D. Mathers et al.
PLOS NEGLECTED TROPICAL DISEASES (2007)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Patricia A. Darrah et al.
NATURE MEDICINE (2007)
Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue
Damien V. Cordery et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Functional characterization of the Plasmodium falciparum and P-berghei homologues of macrophage migration inhibitory factor
Kevin D. Augustijn et al.
INFECTION AND IMMUNITY (2007)
Characterisation of macrophage migration inhibitory factor from Eimeria species infectious to chickens
Katarzyna B. Miska et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2007)
Interleukin-10 and the pathogenesis of human visceral leishmaniasis
Susanne Nylen et al.
TRENDS IN IMMUNOLOGY (2007)
T cell memory and protective immunity by vaccination: is more better?
Maurizio Zanetti et al.
TRENDS IN IMMUNOLOGY (2006)
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival
Diana Starlets et al.
BLOOD (2006)
Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor
L Leng et al.
CELL RESEARCH (2006)
Leishmania vaccines: progress and problems
L. Kedzierski et al.
PARASITOLOGY (2006)
Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis
RT Fujiwara et al.
VETERINARY RESEARCH (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination
EJ Wherry et al.
JOURNAL OF VIROLOGY (2005)
T helper (h)1/Th2 and Leishmania:: paradox rather than paradigm
J Alexander et al.
IMMUNOLOGY LETTERS (2005)
Second-generation vaccines against leishmaniasis
RN Coler et al.
TRENDS IN PARASITOLOGY (2005)
Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis
R Ravindran et al.
CURRENT MOLECULAR MEDICINE (2004)
Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania
A Selvapandiyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cutting edge:: Effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung
AD Roberts et al.
JOURNAL OF IMMUNOLOGY (2004)
Elevated plasma levels of interferon (IFN)-γ, IFN-γ inducing cytokines, and IFN-γ inducible CXC chemokines in visceral leishmaniasis
A Hailu et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2004)
Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection
EG Rhee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Predicting Kala-Azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen
S Singh et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2002)
CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major
Y Belkaid et al.
JOURNAL OF IMMUNOLOGY (2002)
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
V Appay et al.
NATURE MEDICINE (2002)
Asymptomatic human carriers of Leishmania chagasi
CHN Costa et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine
L Gradoni
VETERINARY PARASITOLOGY (2001)
Identification and characterization of a homologue of the pro-inflammatory cytokine Macrophage Migration Inhibitory Factor in the tick, Amblyomma americanum
DC Jaworski et al.
INSECT MOLECULAR BIOLOGY (2001)
Leishmaniasis: Current status of vaccine development
E Handman
CLINICAL MICROBIOLOGY REVIEWS (2001)
Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms
JA Streit et al.
JOURNAL OF IMMUNOLOGY (2001)